Agilent Technologies Inc (NYSE:A) was the recipient of a large growth in short interest in the month of January. As of January 31st, there was short interest totalling 5,190,000 shares, a growth of 11.4% from the January 15th total of 4,660,000 shares. Based on an average trading volume of 1,630,000 shares, the days-to-cover ratio is currently 3.2 days. Currently, 1.7% of the shares of the company are sold short.
Several research firms have recently issued reports on A. UBS Group restated a “buy” rating on shares of Agilent Technologies in a report on Tuesday, January 28th. Wells Fargo & Co began coverage on shares of Agilent Technologies in a report on Tuesday, January 7th. They set an “overweight” rating and a $100.00 price objective on the stock. Citigroup began coverage on shares of Agilent Technologies in a report on Monday, January 6th. They set a “neutral” rating and a $85.00 price objective on the stock. Stifel Nicolaus began coverage on shares of Agilent Technologies in a report on Thursday, November 14th. They set a “hold” rating and a $85.00 price objective on the stock. Finally, HSBC upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a report on Wednesday. Six equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company has an average rating of “Buy” and an average target price of $84.57.
In related news, SVP Dominique Grau sold 15,000 shares of Agilent Technologies stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $82.85, for a total value of $1,242,750.00. Following the transaction, the senior vice president now owns 97,498 shares in the company, valued at approximately $8,077,709.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO Michael R. Mcmullen sold 24,636 shares of Agilent Technologies stock in a transaction on Monday, November 25th. The stock was sold at an average price of $80.00, for a total transaction of $1,970,880.00. Following the completion of the transaction, the chief executive officer now owns 332,121 shares in the company, valued at approximately $26,569,680. The disclosure for this sale can be found here. Insiders sold a total of 89,685 shares of company stock worth $7,470,816 in the last quarter.
Shares of A stock opened at $85.82 on Friday. The firm’s 50 day moving average is $86.17 and its 200-day moving average is $78.39. Agilent Technologies has a 1 year low of $65.35 and a 1 year high of $90.64. The firm has a market capitalization of $26.51 billion, a price-to-earnings ratio of 27.39, a PEG ratio of 2.00 and a beta of 1.41. The company has a current ratio of 1.53, a quick ratio of 1.21 and a debt-to-equity ratio of 0.38.
Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 25th. The medical research company reported $0.89 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.86 by $0.03. Agilent Technologies had a net margin of 20.74% and a return on equity of 20.13%. The business had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same period in the prior year, the business posted $0.81 earnings per share. Agilent Technologies’s revenue was up 5.6% compared to the same quarter last year. On average, equities research analysts forecast that Agilent Technologies will post 3.41 earnings per share for the current fiscal year.
The company also recently announced a quarterly dividend, which was paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st were paid a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.84%. The ex-dividend date was Monday, December 30th. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.16. Agilent Technologies’s dividend payout ratio is presently 23.15%.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.